The potential role of the osteopontin–osteocalcin–osteoprotegerin triad in the pathogenesis of prediabetes in humans

Giuseppe Daniele, Deidre Winnier, Andrea Mari, Jan M Bruder, Marcel Fourcaudot, Zuo Pengou, Andrea Hansis-Diarte, Christopher Jenkinson, Devjit Tripathy, Franco Folli

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Aims: To examine the relationship between hormones involved in bone remodeling and glucose metabolism alterations in prediabetes. Methods: Individuals (n = 43) with NGT (BMI = 31.1 ± 1.1 kg/m2) and individuals (n = 79) with impaired glucose regulation (IGR) (BMI = 31.9 ± 1.2 kg/m2) including subjects with IFG, IGT, and IFG-IGT underwent OGTT and DXA. Osteopontin (OPN), osteocalcin (OCN), osteoprotegerin (OPG), and PTH levels were measured at fasting. Beta-cell function was calculated using C-peptide deconvolution. Dynamic indexes of insulin sensitivity were calculated from OGTT. A subgroup underwent to a euglycemic hyperinsulinemic clamp with 3-3H-glucose to estimate the endogenous glucose production (EGP) and insulin-mediated body glucose disposal (TGD/SSPI).Results: OPN was higher in IGR compared to NGT (5.3 ± 0.5 vs. 3.3 ± 0.2 μg/mL; p = 0.008) and in isolated IGT compared to IFG and IFG-IGT (6.3 ± 0.5 vs. 4.5 ± 0.3 and 5.4 ± 0.5 μg/mL; p = 0.02). OCN was similar in IFG and NGT but lower in IGT and IFG-IGT compared to NGT (7.2 ± 0.3 and 5.4 ± 0.2 vs. 8.3 ± 0.3 ng/mL; p < 0.01). OPN was positively correlated with HbA1c, fasting and 2 h plasma glucose and PTH. OCN was negatively correlated with body fat, 2 h plasma glucose, insulin and positively correlated with Stumvoll index. OPG correlated with TGD/SSPI (r = − 0.29; p < 0.05), EGP, and hepatic insulin resistance index in IGR (r = 0.51, r = 0.43; p < 0.01). There was no correlation between PTH and insulin sensitivity or Beta-cell function parameters. Conclusions: In prediabetes, hormones known to be involved in bone remodeling may affect glucose metabolism before overt T2DM occurs with tissue-specific mechanisms.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalActa Diabetologica
DOIs
StateAccepted/In press - Nov 18 2017

Fingerprint

Prediabetic State
Glucose
Osteopontin
Osteocalcin
Insulin Resistance
Osteoprotegerin
Bone Remodeling
Glucose Tolerance Test
Fasting
Hormones
Insulin
Glucose Clamp Technique
C-Peptide
Adipose Tissue

Keywords

  • Adiponectin
  • Beta-cell function
  • Euglycemic hyperinsulinemic clamp
  • Glucose metabolism
  • Human
  • Impaired fasting glucose
  • Impaired glucose regulation
  • Impaired glucose tolerance
  • Leptin
  • Osteocalcin
  • Osteopontin
  • Osteoprotegerin
  • Prediabetes
  • Type 2 diabetes mellitus
  • Whole body insulin sensitivity

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

The potential role of the osteopontin–osteocalcin–osteoprotegerin triad in the pathogenesis of prediabetes in humans. / Daniele, Giuseppe; Winnier, Deidre; Mari, Andrea; Bruder, Jan M; Fourcaudot, Marcel; Pengou, Zuo; Hansis-Diarte, Andrea; Jenkinson, Christopher; Tripathy, Devjit; Folli, Franco.

In: Acta Diabetologica, 18.11.2017, p. 1-10.

Research output: Contribution to journalArticle

Daniele, G, Winnier, D, Mari, A, Bruder, JM, Fourcaudot, M, Pengou, Z, Hansis-Diarte, A, Jenkinson, C, Tripathy, D & Folli, F 2017, 'The potential role of the osteopontin–osteocalcin–osteoprotegerin triad in the pathogenesis of prediabetes in humans', Acta Diabetologica, pp. 1-10. https://doi.org/10.1007/s00592-017-1065-z
Daniele, Giuseppe ; Winnier, Deidre ; Mari, Andrea ; Bruder, Jan M ; Fourcaudot, Marcel ; Pengou, Zuo ; Hansis-Diarte, Andrea ; Jenkinson, Christopher ; Tripathy, Devjit ; Folli, Franco. / The potential role of the osteopontin–osteocalcin–osteoprotegerin triad in the pathogenesis of prediabetes in humans. In: Acta Diabetologica. 2017 ; pp. 1-10.
@article{43b24fc40d3b49f4aaf3b03358fa00e4,
title = "The potential role of the osteopontin–osteocalcin–osteoprotegerin triad in the pathogenesis of prediabetes in humans",
abstract = "Aims: To examine the relationship between hormones involved in bone remodeling and glucose metabolism alterations in prediabetes. Methods: Individuals (n = 43) with NGT (BMI = 31.1 ± 1.1 kg/m2) and individuals (n = 79) with impaired glucose regulation (IGR) (BMI = 31.9 ± 1.2 kg/m2) including subjects with IFG, IGT, and IFG-IGT underwent OGTT and DXA. Osteopontin (OPN), osteocalcin (OCN), osteoprotegerin (OPG), and PTH levels were measured at fasting. Beta-cell function was calculated using C-peptide deconvolution. Dynamic indexes of insulin sensitivity were calculated from OGTT. A subgroup underwent to a euglycemic hyperinsulinemic clamp with 3-3H-glucose to estimate the endogenous glucose production (EGP) and insulin-mediated body glucose disposal (TGD/SSPI).Results: OPN was higher in IGR compared to NGT (5.3 ± 0.5 vs. 3.3 ± 0.2 μg/mL; p = 0.008) and in isolated IGT compared to IFG and IFG-IGT (6.3 ± 0.5 vs. 4.5 ± 0.3 and 5.4 ± 0.5 μg/mL; p = 0.02). OCN was similar in IFG and NGT but lower in IGT and IFG-IGT compared to NGT (7.2 ± 0.3 and 5.4 ± 0.2 vs. 8.3 ± 0.3 ng/mL; p < 0.01). OPN was positively correlated with HbA1c, fasting and 2 h plasma glucose and PTH. OCN was negatively correlated with body fat, 2 h plasma glucose, insulin and positively correlated with Stumvoll index. OPG correlated with TGD/SSPI (r = − 0.29; p < 0.05), EGP, and hepatic insulin resistance index in IGR (r = 0.51, r = 0.43; p < 0.01). There was no correlation between PTH and insulin sensitivity or Beta-cell function parameters. Conclusions: In prediabetes, hormones known to be involved in bone remodeling may affect glucose metabolism before overt T2DM occurs with tissue-specific mechanisms.",
keywords = "Adiponectin, Beta-cell function, Euglycemic hyperinsulinemic clamp, Glucose metabolism, Human, Impaired fasting glucose, Impaired glucose regulation, Impaired glucose tolerance, Leptin, Osteocalcin, Osteopontin, Osteoprotegerin, Prediabetes, Type 2 diabetes mellitus, Whole body insulin sensitivity",
author = "Giuseppe Daniele and Deidre Winnier and Andrea Mari and Bruder, {Jan M} and Marcel Fourcaudot and Zuo Pengou and Andrea Hansis-Diarte and Christopher Jenkinson and Devjit Tripathy and Franco Folli",
year = "2017",
month = "11",
day = "18",
doi = "10.1007/s00592-017-1065-z",
language = "English (US)",
pages = "1--10",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer-Verlag Italia",

}

TY - JOUR

T1 - The potential role of the osteopontin–osteocalcin–osteoprotegerin triad in the pathogenesis of prediabetes in humans

AU - Daniele, Giuseppe

AU - Winnier, Deidre

AU - Mari, Andrea

AU - Bruder, Jan M

AU - Fourcaudot, Marcel

AU - Pengou, Zuo

AU - Hansis-Diarte, Andrea

AU - Jenkinson, Christopher

AU - Tripathy, Devjit

AU - Folli, Franco

PY - 2017/11/18

Y1 - 2017/11/18

N2 - Aims: To examine the relationship between hormones involved in bone remodeling and glucose metabolism alterations in prediabetes. Methods: Individuals (n = 43) with NGT (BMI = 31.1 ± 1.1 kg/m2) and individuals (n = 79) with impaired glucose regulation (IGR) (BMI = 31.9 ± 1.2 kg/m2) including subjects with IFG, IGT, and IFG-IGT underwent OGTT and DXA. Osteopontin (OPN), osteocalcin (OCN), osteoprotegerin (OPG), and PTH levels were measured at fasting. Beta-cell function was calculated using C-peptide deconvolution. Dynamic indexes of insulin sensitivity were calculated from OGTT. A subgroup underwent to a euglycemic hyperinsulinemic clamp with 3-3H-glucose to estimate the endogenous glucose production (EGP) and insulin-mediated body glucose disposal (TGD/SSPI).Results: OPN was higher in IGR compared to NGT (5.3 ± 0.5 vs. 3.3 ± 0.2 μg/mL; p = 0.008) and in isolated IGT compared to IFG and IFG-IGT (6.3 ± 0.5 vs. 4.5 ± 0.3 and 5.4 ± 0.5 μg/mL; p = 0.02). OCN was similar in IFG and NGT but lower in IGT and IFG-IGT compared to NGT (7.2 ± 0.3 and 5.4 ± 0.2 vs. 8.3 ± 0.3 ng/mL; p < 0.01). OPN was positively correlated with HbA1c, fasting and 2 h plasma glucose and PTH. OCN was negatively correlated with body fat, 2 h plasma glucose, insulin and positively correlated with Stumvoll index. OPG correlated with TGD/SSPI (r = − 0.29; p < 0.05), EGP, and hepatic insulin resistance index in IGR (r = 0.51, r = 0.43; p < 0.01). There was no correlation between PTH and insulin sensitivity or Beta-cell function parameters. Conclusions: In prediabetes, hormones known to be involved in bone remodeling may affect glucose metabolism before overt T2DM occurs with tissue-specific mechanisms.

AB - Aims: To examine the relationship between hormones involved in bone remodeling and glucose metabolism alterations in prediabetes. Methods: Individuals (n = 43) with NGT (BMI = 31.1 ± 1.1 kg/m2) and individuals (n = 79) with impaired glucose regulation (IGR) (BMI = 31.9 ± 1.2 kg/m2) including subjects with IFG, IGT, and IFG-IGT underwent OGTT and DXA. Osteopontin (OPN), osteocalcin (OCN), osteoprotegerin (OPG), and PTH levels were measured at fasting. Beta-cell function was calculated using C-peptide deconvolution. Dynamic indexes of insulin sensitivity were calculated from OGTT. A subgroup underwent to a euglycemic hyperinsulinemic clamp with 3-3H-glucose to estimate the endogenous glucose production (EGP) and insulin-mediated body glucose disposal (TGD/SSPI).Results: OPN was higher in IGR compared to NGT (5.3 ± 0.5 vs. 3.3 ± 0.2 μg/mL; p = 0.008) and in isolated IGT compared to IFG and IFG-IGT (6.3 ± 0.5 vs. 4.5 ± 0.3 and 5.4 ± 0.5 μg/mL; p = 0.02). OCN was similar in IFG and NGT but lower in IGT and IFG-IGT compared to NGT (7.2 ± 0.3 and 5.4 ± 0.2 vs. 8.3 ± 0.3 ng/mL; p < 0.01). OPN was positively correlated with HbA1c, fasting and 2 h plasma glucose and PTH. OCN was negatively correlated with body fat, 2 h plasma glucose, insulin and positively correlated with Stumvoll index. OPG correlated with TGD/SSPI (r = − 0.29; p < 0.05), EGP, and hepatic insulin resistance index in IGR (r = 0.51, r = 0.43; p < 0.01). There was no correlation between PTH and insulin sensitivity or Beta-cell function parameters. Conclusions: In prediabetes, hormones known to be involved in bone remodeling may affect glucose metabolism before overt T2DM occurs with tissue-specific mechanisms.

KW - Adiponectin

KW - Beta-cell function

KW - Euglycemic hyperinsulinemic clamp

KW - Glucose metabolism

KW - Human

KW - Impaired fasting glucose

KW - Impaired glucose regulation

KW - Impaired glucose tolerance

KW - Leptin

KW - Osteocalcin

KW - Osteopontin

KW - Osteoprotegerin

KW - Prediabetes

KW - Type 2 diabetes mellitus

KW - Whole body insulin sensitivity

UR - http://www.scopus.com/inward/record.url?scp=85034222863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034222863&partnerID=8YFLogxK

U2 - 10.1007/s00592-017-1065-z

DO - 10.1007/s00592-017-1065-z

M3 - Article

SP - 1

EP - 10

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

ER -